Modeling Survival Outcomes of Immune Checkpoint Inhibitors on Locally Advanced Non-Small Cell Lung Cancer Following Concurrent Chemoradiotherapy

被引：0
|
作者：
Huang, H. T. [1 ]
Hawkins, M. A. [1 ,2 ]
Fenwick, J. D. [3 ,4 ]
Nix, M. G. [5 ]
机构：
[1] UCL, Dept Med Phys & Biomed Engn, London, England
[2] CRUK RadNet City London, London, England
[3] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool, Merseyside, England
[4] Clatterbridge Canc Ctr, Dept Phys, Wirral, Merseyside, England
[5] Leeds Teaching Hosp NHS Trust, Dept Med Phys & Engn, Leeds, W Yorkshire, England
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2840
引用
收藏
页码：E375 / E375
页数：1
相关论文
共 50 条
  • [21] Outcomes of immune checkpoint inhibitors for postoperative recurrence of non-small cell lung cancer
    Itsuki Yuasa
    Masatsugu Hamaji
    Hiroaki Ozasa
    Yuichi Sakamori
    Hironori Yoshida
    Yojiro Yutaka
    Toshi Menju
    Toyohiro Hirai
    Hiroshi Date
    General Thoracic and Cardiovascular Surgery, 2023, 71 : 534 - 541
  • [22] Concurrent chemoradiotherapy for large-volume locally-advanced non-small cell lung cancer
    Wiersma, Terry G.
    Dahele, Max
    Verbakel, Wilko F. A. R.
    van de Ven, Peter M.
    de Haan, Patricia F.
    Smit, Egbert F.
    van Reij, Ellen J. F.
    Slotman, Ben J.
    Senan, Suresh
    LUNG CANCER, 2013, 80 (01) : 62 - 67
  • [23] Outcomes of immune checkpoint inhibitors for postoperative recurrence of non-small cell lung cancer
    Yuasa, Itsuki
    Hamaji, Masatsugu
    Ozasa, Hiroaki
    Sakamori, Yuichi
    Yoshida, Hironori
    Yutaka, Yojiro
    Menju, Toshi
    Hirai, Toyohiro
    Date, Hiroshi
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2023, 71 (09) : 534 - 541
  • [24] Concurrent chemoradiotherapy in locally advanced non-small cell lung cancer - do the guidelines match the evidence?
    O'Rourke, N
    LUNG CANCER, 2005, 49 : S80 - S80
  • [25] Metformin Use during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
    Wink, Krista
    Belderbos, Jose
    Dieleman, Edith
    Rossi, Maddalena
    Rasch, Coen
    Damhuis, Ronald
    Houben, Ruud
    Troost, Esther
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S278 - S279
  • [26] Concurrent chemoradiotherapy in locally advanced non-small cell lung cancer: Comparison of two treatment regimens
    Leclerc, M.
    Raby, B.
    Laberge, F.
    Fournier, B.
    Martin, S.
    Lacasse, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S453 - S453
  • [27] Acute and Late Toxicities of Concurrent Chemoradiotherapy for Locally-Advanced Non-Small Cell Lung Cancer
    Verma, Vivek
    Simone, Charles B., II
    Werner-Wasik, Maria
    CANCERS, 2017, 9 (09)
  • [28] CONCURRENT CHEMORADIOTHERAPY IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER: COMPARISON OF TWO TREATMENT REGIMENS
    Leclerc, M.
    Raby, B.
    Leberge, F.
    Fournier, B.
    Martin, S.
    Lacasse, Y.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S60 - S61
  • [29] Concurrent Chemoradiotherapy with Biweekly Gemcitabine and Cisplatin in Patients with Locally Advanced Non-small Cell Lung Cancer
    Oak, Chul Ho
    Kim, Ja Kyung
    La Jang, Lee
    Moon, Dae Sung
    Jang, Tae Won
    Jung, Maan Hong
    Cho, Sung Whan
    Jeung, Tae Sig
    RADIATION ONCOLOGY JOURNAL, 2008, 26 (03): : 160 - 165
  • [30] Consolidation Chemotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer After Concurrent Chemoradiotherapy
    Basal, F.
    Aslan, F.
    Zengin, G.
    Demirci, U.
    Oksuzoglu, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S853 - S853
12345